RECURRENT MENINGIOMA
Clinical trials for RECURRENT MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MENINGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy meets radiation in fight against recurrent meningioma
Disease control OngoingThis study is for people with a rare, aggressive brain tumor called high-grade meningioma that has come back after radiation. It tests whether adding immunotherapy drugs (nivolumab with or without ipilimumab) to precise, high-dose radiation can help shrink the tumor or slow its g…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy aims to stop returning brain tumors
Disease control OngoingThis phase II trial tests whether combining stereotactic radiosurgery (precise, high-dose radiation) with the immunotherapy drug pembrolizumab (Keytruda) can help control recurrent meningioma, a type of brain tumor. The study enrolls 35 adults whose tumors have returned after pri…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Nancy Ann Oberheim Bush, MD • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New radiation strategy aims to tackle tough brain tumors
Disease control TerminatedThis early-phase trial tests whether giving higher doses of radiation, guided by special PET/MRI scans, is safe for people with high-risk meningiomas (aggressive or recurrent brain tumors). About 24 adults will receive one of four radiation dose levels to find the highest dose th…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC